News: Archive for March 2024
MicroPharm’s Cilgerran Manufacturing Site licensed by the MHRA
MicroPharm’s Cilgerran Manufacturing Site granted MIA, MIA (IMP) and “Specials” licences by the MHRA.
Read the full storyPosted on: Monday, 11th March 2024
A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events
MicroPharm’s Cilgerran Manufacturing Site granted MIA, MIA (IMP) and “Specials” licences by the MHRA.
Read the full storyPosted on: Monday, 11th March 2024